BLEVF — Beleave Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $8.90m
- CA$2.37m
Annual cashflow statement for Beleave, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.51 | -2.99 | -8.55 | -12.6 | -33.8 |
| Depreciation | |||||
| Non-Cash Items | 0 | 2.21 | 6.01 | 8.07 | 21.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.138 | 0.417 | 1.28 | -1.64 | -0.017 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.372 | -0.36 | -1.26 | -5.88 | -9.47 |
| Capital Expenditures | -0.862 | -0.039 | -1 | -1.68 | -8.74 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.221 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.862 | -0.039 | -1 | -1.68 | -8.96 |
| Financing Cash Flow Items | — | — | -0.038 | -0.003 | -6.64 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.358 | 0.399 | 4.09 | 17.5 | 6.97 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.876 | -0 | 1.83 | 9.94 | -11.5 |